# Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial

Study · id `cardio:ct-nct02848781` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02848781](<https://clinicaltrials.gov/study/NCT02848781>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02848781

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

## Technical summary

Registry record NCT02848781. Randomized; no masking; primary purpose treatment. Start 2015-11-30 (actual); primary completion 2021-03-29 (actual). Results posted on 2022-12-14.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 180 participants (enrolled count; ClinicalTrials.gov record NCT02848781, source copy `cardio:ctgov-nct02848781-2022-12-14`, retrieved 2026-10-26)
- Started: 2015-11-30 (actual) (ClinicalTrials.gov record NCT02848781, source copy `cardio:ctgov-nct02848781-2022-12-14`, retrieved 2026-10-26)
- Primary completion: 2021-03-29 (actual) (ClinicalTrials.gov record NCT02848781, source copy `cardio:ctgov-nct02848781-2022-12-14`, retrieved 2026-10-26)
- Completion: 2021-03-29 (actual) (ClinicalTrials.gov record NCT02848781, source copy `cardio:ctgov-nct02848781-2022-12-14`, retrieved 2026-10-26)
- Results first posted: 2022-12-14 (ClinicalTrials.gov record NCT02848781, source copy `cardio:ctgov-nct02848781-2022-12-14`, retrieved 2026-10-26)
- Countries: United States; China; Japan; South Korea; Taiwan (ClinicalTrials.gov record NCT02848781, source copy `cardio:ctgov-nct02848781-2022-12-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02848781-2022-12-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial
- Acronym: PAUSE-SCD
- Condition: Ventricular Tachycardia (VT)
- Intervention (Device): Implantable Cardioverter Defibrillator (ICD)
- Intervention (Procedure): Catheter Ablation
- Lead sponsor: University of Arizona
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: University of Arizona (`cardio:org-university-of-arizona`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial (`cardio:pubmed-35507499`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6c0230a3398c451ffd1713db174a14024b43bd3518812f186098bffaa2fd5175
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
